Author: Maureen Shaffer
On May 26th, FDA announced that they consolidated all enforcement actions in one place. Why is this good for you? If you are in marketing, regulatory or legal, it is one-stop shopping for FDA case studies of illegal medical device and pharmaceutical marketing.
However, it is a government database. Navigation is complex to find meaningful and actionable data. In my next series of seven (7) blog posts, I will offer one idea for how-to use this database, complete with easy-to-follow steps.
For now, happy surfing!
- Main database for FDA enforcement actions
- For violative promotion letters, jump to the Warning Letters Database